BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 31287913)

  • 1. Role of the endolysosomal system in Parkinson's disease.
    Vidyadhara DJ; Lee JE; Chandra SS
    J Neurochem; 2019 Sep; 150(5):487-506. PubMed ID: 31287913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRK2 and the Endolysosomal System in Parkinson's Disease.
    Erb ML; Moore DJ
    J Parkinsons Dis; 2020; 10(4):1271-1291. PubMed ID: 33044192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endosomal sorting pathways in the pathogenesis of Parkinson's disease.
    Cunningham LA; Moore DJ
    Prog Brain Res; 2020; 252():271-306. PubMed ID: 32247367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.
    Nguyen M; Wong YC; Ysselstein D; Severino A; Krainc D
    Trends Neurosci; 2019 Feb; 42(2):140-149. PubMed ID: 30509690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Evidence for Endolysosomal Dysfunction in Parkinson's Disease: A Critical Overview.
    Yahya V; Di Fonzo A; Monfrini E
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-Synuclein and the Endolysosomal System in Parkinson's Disease: Guilty by Association.
    Teixeira M; Sheta R; Idi W; Oueslati A
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of autophagy and vesicle trafficking in Parkinson's disease.
    Sheehan P; Yue Z
    Neurosci Lett; 2019 Apr; 697():59-65. PubMed ID: 29627340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.
    Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Parkinson's disease in LRRK2 mice: focus on synaptic dysfunction and the autophagy-lysosomal pathway.
    Albanese F; Domenicale C; Volta M; Morari M
    Biochem Soc Trans; 2022 Feb; 50(1):621-632. PubMed ID: 35225340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations.
    Li H; Ham A; Ma TC; Kuo SH; Kanter E; Kim D; Ko HS; Quan Y; Sardi SP; Li A; Arancio O; Kang UJ; Sulzer D; Tang G
    Autophagy; 2019 Jan; 15(1):113-130. PubMed ID: 30160596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's: A Disease of Aberrant Vesicle Trafficking.
    Singh PK; Muqit MMK
    Annu Rev Cell Dev Biol; 2020 Oct; 36():237-264. PubMed ID: 32749865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective autophagy in Parkinson's disease: lessons from genetics.
    Zhang H; Duan C; Yang H
    Mol Neurobiol; 2015 Feb; 51(1):89-104. PubMed ID: 24990317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal impairment in Parkinson's disease.
    Dehay B; Martinez-Vicente M; Caldwell GA; Caldwell KA; Yue Z; Cookson MR; Klein C; Vila M; Bezard E
    Mov Disord; 2013 Jun; 28(6):725-32. PubMed ID: 23580333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease.
    Tang FL; Erion JR; Tian Y; Liu W; Yin DM; Ye J; Tang B; Mei L; Xiong WC
    J Neurosci; 2015 Jul; 35(29):10613-28. PubMed ID: 26203154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease.
    Nguyen M; Krainc D
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5576-5581. PubMed ID: 29735704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease mechanisms as subtypes: Lysosomal dysfunction in the endolysosomal Parkinson's disease subtype.
    Mamais A; Wallings R; Rocha EM
    Handb Clin Neurol; 2023; 193():33-51. PubMed ID: 36803821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine transporter and synaptic vesicle sorting defects underlie auxilin-associated Parkinson's disease.
    Vidyadhara DJ; Somayaji M; Wade N; Yücel B; Zhao H; Shashaank N; Ribaudo J; Gupta J; Lam TT; Sames D; Greene LE; Sulzer DL; Chandra SS
    Cell Rep; 2023 Mar; 42(3):112231. PubMed ID: 36920906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of VPS35 in the Pathobiology of Parkinson's Disease.
    Sassone J; Reale C; Dati G; Regoni M; Pellecchia MT; Garavaglia B
    Cell Mol Neurobiol; 2021 Mar; 41(2):199-227. PubMed ID: 32323152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
    Koentjoro B; Park JS; Sue CM
    Sci Rep; 2017 Mar; 7():44373. PubMed ID: 28281653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.